CFDE Data Portal | Search UBXN11

	Label	Description
	UBXN11 associations Collection (Entity type)	Associations for UBXN11_associations
	UBXN11 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	UBXN11 Gene (Entity type)	ENSG00000158062 - UBX domain protein 11
	KFGENEBIN:UBXN11-variant-count CUI gene has variants UBXN11 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Kids First
	GSE199688 artemisinin 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE193351 ruxolitinib 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE216043 cisplatin 11 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE216043 cisplatin 7 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE120612 7 V 5 ETOPOSIDE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE181517 0 V 1 DOXORUBICIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS

UBXN11 associations

Associations for UBXN11_associations

UBXN11 associations.tsv

A file from IDG as part of the Harmonizome project

UBXN11

ENSG00000158062 - UBX domain protein 11

KFGENEBIN:UBXN11-variant-count CUI gene has variants UBXN11

A Knowledge Graph Assertion from Kids First

GSE199688 artemisinin 0 v 1 human dn

A Gene Set from LINCS

GSE193351 ruxolitinib 1 v 2 human dn

A Gene Set from LINCS

GSE216043 cisplatin 11 v 2 human dn

A Gene Set from LINCS

GSE216043 cisplatin 7 v 0 human dn

A Gene Set from LINCS

GSE120612 7 V 5 ETOPOSIDE HUMAN UP

A Gene Set from LINCS

GSE181517 0 V 1 DOXORUBICIN HUMAN DN

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.